RESUME SUMMARY

                                                I. BACKGROUND HIGHLIGHTS:

Harvard College (Cambridge) (1954-58):

            Graduated with Honors in Social Relations.                                    

            Directed Harvard-Radcliffe Mental Hospital Volunteer Program.     

            Research grants from Harvard Medical School and the National Institute of Mental Health (NIMH).      

            Co-authored 1^st professional book, College Students in a Mental Hospital (1962)..

Case Western Reserve School of Medicine (Cleveland) (1958-1962):          

            Conducted four years of psychopharmacology lab research with controlled animal trials supported by NIMH grant, resulting in first two published papers in psychopharmacology.

            Special four-year individual tutorial with pediatrician Benjamin Spock, M.D.         

Diplomat, National Board of Medical Examiners (1963):

            Highest grade in country (99%) on psychiatry portion of boards used to qualify for medical licenses.          

Massachusetts Mental Health Center (Boston) (1963-64): 

            First Year Resident in Psychiatry at the main Harvard teaching hospital. 

            Teaching Fellow at Harvard Medical School.          

State University of New York Upstate Medical Center (Syracuse) (1962-63, 1964-66): 

            Intern in Mixed Medicine and Psychiatry. 

            Second and Third Year Resident and Teaching Assistant in Psychiatry.             

National Institute of Mental Health (NIMH) and U. S. Public Health Service Officer (Charlottesville, VA and Bethesda, MD) (1966-68):  

            Full-time NIMH Consultant in Building and Staffing Community Mental Health   Centers (1966-67). 

            Full-time NIMH Consultant in Mental Health and Education (1967-68).

University of Maryland (1968-1970): 

            Faculty, courses in counseling department. 

Washington School of Psychiatry (1968-1972): 

            Faculty, courses for school counselors. 

George Mason University (1990-96):          

            Adjunct Professor of Conflict Analysis and Resolution, courses on brain and behavior.           

Johns Hopkins University (1996-99):

            Faculty Associate in the Department of Counseling and Human Services, courses including psychopharmacology and diagnosis in psychiatry.

                               II. HIGHLIGHTS OF PROFESSIONAL ACTIVITIES:

 Private Practice of Psychiatry, Washington, DC and Bethesda, MD. (1968-2002):          

             Full-time private practice with individuals, families, and children. 

            Subspecialty clinical psychopharmacology and the drug approval process. 

Private Practice of Psychiatry, Ithaca, New York.  (2003-present):          

            In November 2002, all of my professional activities moved to Ithaca, New York.   

Founder and Director, International Center for the Study of Psychiatry and Psychology (1972-2002) and Director Emeritus (2002-present): 

Founded and directed reform organization called "the conscience of psychiatry" including a professional peer-reviewed journal, annual scientific meetings and two thousand members.            

Editor-in-Chief (1998-2002) and Founding Editor and Consultant (2002-present) of Ethical Human Sciences and Services: An International Journal of Critical Inquiry.

Founded and edited a peer-reviewed journal with 40 contributing editors published by Springer Publishing Company.

 Editorial Consultant (mostly current): 

International Journal of Risk and Safety in Medicine
The Psychotherapy Patient
Journal of Critical Psychology, Counselling and Psychotherapy: Journal of the Psychology and Psychotherapy Association
The Humanistic Psychologist
Journal of Mind and Behavior
Hospital and Community Psychiatry (reviewer in past)

Scientific Presenter at Conferences, Grand Rounds, Universities:  

Hundreds of invited scientific presentations on psychopharmacology, shock treatment, psychosurgery, psychotherapy, and legal issues, including to the National Institutes of Health (NIH) Consensus Development Conferences on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (November 1998); the NIH Consensus Development Conference on Electroconvulsive Therapy (1985); National Institutes of Health Panel on NIH Research on Anti-social, Aggressive and Violence-related Behaviors and Their Consequences (1994);  National Institute of Mental Health (NIMH) Guest Speakers Program; U.S. House of Representatives Committee on Education (September 2000); American Psychiatric Association; NIH Institute on Hospital and Community Psychiatry; American Psychological Association; American Orthopsychiatry Association; American Autism Society; American Association for the Advancement of Science; American Counseling Association, Connecticut Psychiatric Society Residents Program, Harvard University School of Education Special Lecture; Georgetown University School of Medicine Department of Pharmacology; New Jersey Medical School Department of Psychiatry Annual Medical Forum; Walter Reed Army Hospital Psychiatric Residency Program; National Naval Medical Center; Metropolitan Hospital Center/New York Medical College Department of Psychiatry; Manhattan State Hospital (New York City) Grand Rounds; Spring Grove Hospital (Maryland) CME Credit Seminars; Chestnut Lodge Hospital Case Conference; St. Elizabeths Hospital Grand Rounds and Seminars (Washington, DC); Regents College of Psychotherapy and Counseling (London); Institute for Genetics (Cologne); Royal Ottawa Hospital Grand Rounds (Canada); MIND of Great Britain; University of Sheffield Department of Psychiatry (England).

Advanced Training Courses:

            Psychopharmacology, drug development, drug labeling and the FDA.          

Medical Expert and Researcher: 

I have testified in many cases in past 25 years including criminal, malpractice, product liability and class action, often involving psychopharmacology, including neuroleptic-induced tardive dyskinesia and SSRI-induced violence and suicide.  

Some of the suits in which I have been involved, and some of research I have published, resulted in changes being made in the FDA-approved labels for neuroleptics and SSRI antidepressants.  

A few highlights include:

            (1)  Medical expert in Kaimowitz v. Department of Mental Health, Wayne County, Michigan (1973).  The three-judge panel followed my testimony in an opinion that helped to stop lobotomy and psychosurgery in the state and federal facilities around the country. 

            (2) Medical expert for the 100 or more combined Prozac product liability suits (1992-1994) against Eli Lilly, including the famous Wesbecker trial (Fentress et al.) that the drug company secretly settled in a controversial manipulation of the court system.

            (3 Medical expert and consultant in many tardive dyskinesia malpractice and product liability suits.

            (4 Medical expert in numerous criminal cases with defenses based on involuntary intoxication with psychiatric drugs. 

            (5) Invited Scientific Presenter on adverse drug effects in children at the November 1998 National Institutes of Health (NIH) Consensus Development Conference on the Diagnosis and Treatment of Attention Deficit Disorder.

            (6)  Medical consultant for the FAA (Federal Aviation Agency) concerning effects of SSRIs on pilots (1998-2000).

            (7) Testimony before the Food and Drug Administration (FDA) on the dangers of SSRI antidepressants in children (February 2004). The published opinion of the FDA panel closely paralleled my testimony and publications about the overall risk of stimulation (activation) with the potential for agitation, violence and suicide. 

Memberships:          

           American Psychiatric Association (Life Member)
           American Orthopsychiatry Association (Fellow)
           Canadian Psychiatric Association
           Royal Society of Medicine
           Regulatory Affairs Professionals Society (RAPS)
           Drug Information Association (DIA)
          World Association of Medical Editors 

Medical Licenses: 

            New York State, Washington, D.C., Maryland, and Virginia.          

Publications: 

            19 professional books and more than 30 peer-reviewed journal articles, many in  the area of psychopharmacology (see below for details).

III. PROFESSIONAL BOOKS (1962-present): 

            1. College Students in a Mental Hospital: Contribution to the Social Rehabilitation of the Mentally Ill (New York, Grune & Stratton, 1962)

               (jointly authored by Carter Umbarger, James Dalsimer, Andrew Morrison, and Peter Breggin).  

            2. Electroshock: Its Brain-Disabling Effects (Springer, NY, 1979).          

            3. The Psychology of Freedom: Liberty and Love as a Way of Life Buffalo, Prometheus Books, 1980.         

            4. Psychiatric Drugs: Hazards to the Brain (Springer, NY, 1983).

            5. Toxic Psychiatry (St. Martin's, NY, 1991). 

            6. Beyond Conflict (St. Martin's, NY, 1992).

            7. Talking Back to Prozac (with Ginger Breggin) (St. Martin's, NY, 1994). 

            8. The War Against Children (with Ginger Breggin) (St. Martin's, NY, 1994).                                              

            9. Psychosocial Approaches to Deeply Disturbed Persons  (senior editor) (Haworth Press, NY, 1996). 

            10. Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock and the Role of the FDA (Springer, NY, 1997). 

            11. The Heart of Being Helpful: Empathy and the Creation of a Healing Presence (Springer, NY, 1997). 

            12. Talking Back To Ritalin (Common Courage Press, ME, 1998). 

            13. The War Against Children of Color: Psychiatry Targets Inner City Children. (Common Courage Press, ME, 1998)  (with G. Breggin)

                 Revision and update of The War Against Children. 

            14. Your Drug May Be Your Problem: How and Why To Stop Taking Psychiatric Medications.  (Perseus Books, Cambridge, MA, 1999)

                (Co-authored by David Cohen, Ph.D.). 

            15. Reclaiming Our Children: A Healing Solution to a Nation in Crisis. (Perseus Books, Cambridge, MA, 2,000).          

            16. Talking Back to Ritalin, Revised Edition.  (Perseus Books, Cambridge, MA, 2001).          

            17.  The Antidepressant Fact book.  (Perseus Books, Cambridge, MA, 2001) 

            18. Dimensions of Empathic Therapy (jointly co-edited by Ginger Breggin and Fred Bemak) (Springer, NY, 2002). 

            19. The Ritalin Fact Book.  (Perseus Books, Cambridge, MA, 2002). 

IV. PEER-REVIEWED PUBLICATIONS (1964-present): 

            1. "The Psychophysiology of Anxiety."  Journal of Nervous Mental Diseases 139:558-568, 1964. 

            2. "Coercion of Voluntary Patients in an Open Hospital."  Archives of General Psychiatry 10:173-181, 1964.  Reprinted with a new introduction in Edwards, R.B. (ed): Psychiatry and Ethics.  Buffalo, Prometheus Books, 1982, and in Edwards, R.B. (ed): Ethics of Psychiatry. Amherst, New York, Prometheus Books, 1997. 

            3. "The Sedative-like Effect of Epinephrine."  Archives of General Psychiatry  12:255-259, 1965. 

            4. "Psychotherapy as Applied Ethics."  Psychiatry 34:59-75, 1971. 

            5. "Therapy as Applied Utopian Politics."  Mental Health and Society 1:129-146, 1974. 

            6. "Psychiatry and Psychotherapy as Political Processes."  American Journal of Psychotherapy 29:369-382, 1975. 

            7. "Madness is a Failure of Free Will; Therapy Too Often Encourages It."  Psychiatric Quarterly 53:61-68, 1981.  Originally published (in French) in Verdiglione A (ed):La Folie Dans La Psychoanalyse.  Paris, Payot, 1977. 

            8. "Electroshock Therapy and Brain Damage: The Acute Organic Brain Syndrome as Treatment."  Behavior and Brain Sciences 7:24-25, 1984 

            9. "Neuropathology and Cognitive Dysfunction from ECT."  Psychopharmacology Bulletin  22:476-479, 1986. 

            10. "Ellettroshock: Tra Rischioiatrogeno e Mito Terapeutico."  (P. Breggin and G. de Girolamo)  Quaderni Italiani di Psychiatrica 6:497-540, 1987. 

            11. "The Three Dynamics of Human Progress: A Unified Theory Applicable to Individuals, Institutions and Society."  Review of Existential Psychology and Psychiatry 21:(Nos. 1-3)97-123, 1988-89. 

            12. "Precious the Crow."  Voices (Journal of the American Academy of Psychotherapists) 23:32-42, Summer 1987.

            13. "Brain Damage, Dementia and Persistent Cognitive Dysfunction Associated with Neuroleptic Drugs: Evidence, Etiology, Implications."  Journal of Mind Behavior 11:425-464, 1990. 

            14. "Psychotherapy in the Shadow of the Psycho-Pharmaceutical Complex," Voices (journal of the American Academy of Psychotherapists) 27:15-21, 1991. 

            15. "A Case of Fluoxetine-induced Stimulant Side Effects with Suicidal Ideation Associated with a Possible Withdrawal Syndrome ("Crashing")."  International Journal of Risk & Safety in Medicine 3:325-328, 1992. 

            16. "Parallels Between Neuroleptic Effects and Lethargic Encephalitis: The Production of Dyskinesias and Cognitive disorders."  Brain and Cognition 23:8-27, 1993.

             17. "A Biomedical Programme for Urban Violence Control in the US: The Dangers of Psychiatric Social Control."  (Peter Breggin and Ginger Ross Breggin). Changes: An International Journal of Psychology and Psychotherapy 11, No. 1 (March):59-71, 1993.  

            18. "Psychiatry's Role in the Holocaust."  International Journal of Risk and Safety in Medicine 4:133-148, 1993.  Adapted from a paper delivered at "Medical Science Without Compassion" in Cologne, Germany and published in the conference proceedings. 

            19. "Should the Use of Neuroleptics Be Severely Limited?"  Changes: An International Journal of Psychology and Psychotherapy  14:62-66  March 1996.        

            20. "The Hazards of Treating 'Attention-Deficit/Hyperactivity Disorder' with Methylphenidate (Ritalin)" (coauthored by Ginger Breggin) Journal of College Student Psychotherapy 10:55-72, 1996. 

            21. "Psychotherapy in Emotional Crises without Resort to Psychiatric Medication." The Humanistic Psychologist 25:2-14, 1998. 

            22. "Analysis of Adverse Behavioral Effects of Benzodiazepines with a Discussion of Drawing Scientific Conclusions from the FDA's Spontaneous Reporting System."  Journal of Mind and Behavior 19:21-50, 1998. 

            23. "Electroshock: Scientific, ethical, and political issues.”  International Journal of Risk & Safety In Medicine 11:5-40, 1998. 

            24. "Psychostimulants in the treatment of children diagnosed with ADHD: Part I—Acute risks and psychological effects."  Ethical Human Sciences and Services 1:13-33, 1999. 

            25. "Psychostimulants in the treatment of children diagnosed with ADHD: Part II—Adverse effects on brain and behavior.”  Ethical Human Sciences and Services 1:213-241, 1999.  

            26. "Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanism of action."  International Journal of Risk and Safety in Medicine, 12 (1), 3-35, 1999.  (Simultaneously published version of #’s 24 and 25) 

            27. "Empathic self-transformation and love in individual and family therapy."  Humanistic Psychologist, 27:267-282, 1999. 

            28. "What psychologists and psychotherapists need to know about ADHD and stimulants."  Changes: An International Journal of Psychology and Psychotherapy 18:13-23, Spring 2000. 

            29. "The NIMH multimodal study of treatment for attention-deficit/hyperactivity disorder: A critical analysis."  International Journal of Risk and Safety in Medicine 13:15-22, 2000.          

            30. "Empowering social work in the era of biological psychiatry." (2001) [The annual Ephraim Lisansky lecture of the University of Maryland School of Social Work.]  Ethical Human Sciences and Services 3:197-206. 

            31. "Fluvoxamine as a cause of stimulation, mania, and aggression with a critical analysis of the FDA-approved label."  International Journal of Risk and Safety in Medicine, 14: 71-86, 2002. 

            32. “Psychopharmacology and human values.”  Journal of Humanistic Psychology, 43: 34-49, 2003.        

            33. “Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): A review and analysis.” Ethical Human Sciences and Services 5:225-246, 2003. Simultaneously published in the International Journal of Risk and Safety in Medicine, 16, 31-49, 2003/2004.

            34. “Recent U.S., Canadian and British regulatory agency actions concerning antidepressant-induced harm to self and others: A review and analysis.” Ethical Human Psychology and Psychiatry, 7, 7-22, 2005. Simultaneously published in the International Journal of Risk and Safety in Medicine, 16, 247-259, 2005.

            35. “Recent regulatory changes in antidepressant labels: Implications for activation (stimulation) in clinical practice.” Primary Psychiatry, 13, 57-60, 2006